Brief: Cumberland Pharmaceuticals Reports 17% Revenue Growth For The Full Year 2019

Cumberland Pharmaceuticals

18/03/2020 22:14

March 18 (Reuters) - Cumberland Pharmaceuticals Inc
 CPIX.O :
    * CUMBERLAND PHARMACEUTICALS REPORTS 17% REVENUE GROWTH FOR
THE
FULL YEAR 2019
    * Q4 ADJUSTED EARNINGS PER SHARE $0.09
    * Q4 REVENUE ROSE 1 PERCENT TO $13.7 MILLION
    * RECEIVED FDA APPROVAL FOR REDITREX
    * CUMBERLAND PHARMACEUTICALS - INITIATED NEW IFETROBAN
CLINICAL
PROGRAM
    * CUMBERLAND PHARMACEUTICALS - QTRLY LOSS PER SHARE $0.06

Source text for Eikon:  ID:nPn9sTL8fa 
Further company coverage:  CPIX.O 

 ((Reuters.Briefs@thomsonreuters.com;))